SCHEMBL13503162

SCHEMBL13503162

C=CCS(C)(CCC)CCCS

nearest known ligand 0.31

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.31
TSHR P16473 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13503166 0.83
SCHEMBL18829643 0.82 TSHR (0.36) ALDH1A1TSHR
SCHEMBL16326627 0.74
SCHEMBL3851447 0.68 TSHR (0.32) TSHR
SCHEMBL25461075 0.67
SCHEMBL25453522 0.66 TSHR (0.35) ALDH1A1TSHR
SCHEMBL21928554 0.61
Butadiene SCHEMBL10731281 0.61
SCHEMBL22999495 0.61 TSHR (0.33) TSHR
SCHEMBL2985516 0.61

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100034789-A1 Novel carbosilane dendrimers, preparation method thereof and use of same N-LIFE THERAPEUTICS, S.L. (ES) 2010-02-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100034789-A1 Novel carbosilane dendrimers, preparation method thereof and use of same CD14, DNMT1, PCNA ALDH1A1 4747/4885TSHR 2826/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.